Jiangxi Synergy Pharmaceutical Co Ltd (300636) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangxi Synergy Pharmaceutical Co Ltd (300636) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥65.40 Million ≈ $9.57 Million USD) by net assets (CN¥2.38 Billion ≈ $347.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300636 stock market capitalisation for the company's overall valuation and market capitalisation.
Jiangxi Synergy Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Jiangxi Synergy Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jiangxi Synergy Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangxi Synergy Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Jiangxi Synergy Pharmaceutical Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
-0.147x |
|
Paslin Digital Technology Co Ltd
SHG:600215
|
0.030x |
|
Vietnam Construction and Import Export JSC
VN:VCG
|
-0.005x |
|
Guizhou Yibai Pharmaceutical Co Ltd
SHG:600594
|
0.015x |
|
Xerox Corp
NASDAQ:XRX
|
0.067x |
|
Tianjin Ruixin Technology Co Ltd
SHE:300828
|
0.024x |
|
Facc AG
VI:FACC
|
0.002x |
|
WinMate Communication INC
TW:3416
|
0.004x |
Annual Cash Flow Conversion Efficiency for Jiangxi Synergy Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Jiangxi Synergy Pharmaceutical Co Ltd from 2012 to 2025. View 300636 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.37 Billion ≈ $346.11 Million |
CN¥202.07 Million ≈ $29.57 Million |
0.085x | -30.84% |
| 2024-12-31 | CN¥2.31 Billion ≈ $337.84 Million |
CN¥285.19 Million ≈ $41.73 Million |
0.124x | +67.95% |
| 2023-12-31 | CN¥2.23 Billion ≈ $325.80 Million |
CN¥163.75 Million ≈ $23.96 Million |
0.074x | -50.48% |
| 2022-12-31 | CN¥1.32 Billion ≈ $193.11 Million |
CN¥196.00 Million ≈ $28.68 Million |
0.149x | +0.43% |
| 2021-12-31 | CN¥888.11 Million ≈ $129.96 Million |
CN¥131.34 Million ≈ $19.22 Million |
0.148x | +50.81% |
| 2020-12-31 | CN¥816.50 Million ≈ $119.48 Million |
CN¥80.07 Million ≈ $11.72 Million |
0.098x | +344.98% |
| 2019-12-31 | CN¥706.31 Million ≈ $103.36 Million |
CN¥-28.27 Million ≈ $-4.14 Million |
-0.040x | -135.16% |
| 2018-12-31 | CN¥658.16 Million ≈ $96.31 Million |
CN¥74.93 Million ≈ $10.96 Million |
0.114x | +113.00% |
| 2017-12-31 | CN¥637.10 Million ≈ $93.23 Million |
CN¥34.05 Million ≈ $4.98 Million |
0.053x | -73.06% |
| 2016-12-31 | CN¥304.66 Million ≈ $44.58 Million |
CN¥60.45 Million ≈ $8.85 Million |
0.198x | -38.38% |
| 2015-12-31 | CN¥246.66 Million ≈ $36.09 Million |
CN¥79.42 Million ≈ $11.62 Million |
0.322x | -41.08% |
| 2014-12-31 | CN¥118.02 Million ≈ $17.27 Million |
CN¥64.50 Million ≈ $9.44 Million |
0.547x | +198.77% |
| 2013-12-31 | CN¥78.82 Million ≈ $11.53 Million |
CN¥14.42 Million ≈ $2.11 Million |
0.183x | +406.36% |
| 2012-12-31 | CN¥45.51 Million ≈ $6.66 Million |
CN¥-2.72 Million ≈ $-397.62K |
-0.060x | -- |
About Jiangxi Synergy Pharmaceutical Co Ltd
Jiangxi Synergy Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and fine chemicals in China and internationally. The company offers API products for anti-epilepsy and pain treatment, anti-inflammatory, gastrointestinal, anti-hypertension, anti-gout, anti-… Read more